Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.780
-0.060 (-2.11%)
At close: Feb 21, 2025, 4:00 PM
2.870
+0.090 (3.24%)
After-hours: Feb 21, 2025, 7:55 PM EST
Perspective Therapeutics Stock Forecast
CATX's stock price has decreased by -69.62% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Perspective Therapeutics stock have an average target of 17.25, with a low estimate of 6.00 and a high estimate of 22. The average target predicts an increase of 520.50% from the current stock price of 2.78.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 14, 2025.
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 4 | 4 | 4 | 4 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $16 | Buy | Reiterates | $16 | +475.54% | Jan 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $25 → $16 | Buy | Maintains | $25 → $16 | +475.54% | Nov 25, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $24 → $6 | Strong Buy → Hold | Downgrades | $24 → $6 | +115.83% | Nov 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $16 | Buy | Maintains | $22 → $16 | +475.54% | Nov 22, 2024 |
| Wedbush | Wedbush | Buy Reiterates $20 | Buy | Reiterates | $20 | +619.42% | Oct 24, 2024 |
Financial Forecast
Revenue This Year
1.43M
from 1.43M
Decreased by -0.14%
Revenue Next Year
751.13K
from 1.43M
Decreased by -47.55%
EPS This Year
-0.87
from -1.74
EPS Next Year
-1.28
from -0.87
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 2.1M | 2.5M | 2.5M | |||
| Avg | 1.4M | 751,128 | 759,778 | |||
| Low | 980,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 45.0% | 74.5% | 235.5% | |||
| Avg | -0.1% | -47.5% | 1.2% | |||
| Low | -31.7% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.40 | -1.04 | -0.78 | ||
| Avg | -0.87 | -1.28 | -1.53 | ||
| Low | -1.18 | -1.81 | -2.02 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.